Pulmonx Corp — Director's Dealing 2022

Mar 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-03-01

Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-01	Common Stock	S	426	$25.91	Disposed	123702	Direct
2022-03-01	Common Stock	A	31000	$0.00	Acquired	154702	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-01	Employee Stock Option (right to buy)	$26.56	A	68700	Acquired	2032-02-29	Common Stock (68700)	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: Includes 669 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2022.

F3: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.

F4: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.